Cargando…

The dawn has come for new therapeutics to treat atherosclerosis: Targeting neuroimmune cardiovascular interfaces in artery brain circuits

Detalles Bibliográficos
Autores principales: Mohanta, Sarajo Kumar, Weber, Christian, Yin, Changjun, Habenicht, Andreas J. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437971/
https://www.ncbi.nlm.nih.gov/pubmed/36052959
http://dx.doi.org/10.1002/ctm2.1040
_version_ 1784781728609468416
author Mohanta, Sarajo Kumar
Weber, Christian
Yin, Changjun
Habenicht, Andreas J. R.
author_facet Mohanta, Sarajo Kumar
Weber, Christian
Yin, Changjun
Habenicht, Andreas J. R.
author_sort Mohanta, Sarajo Kumar
collection PubMed
description
format Online
Article
Text
id pubmed-9437971
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-94379712022-09-09 The dawn has come for new therapeutics to treat atherosclerosis: Targeting neuroimmune cardiovascular interfaces in artery brain circuits Mohanta, Sarajo Kumar Weber, Christian Yin, Changjun Habenicht, Andreas J. R. Clin Transl Med Commentary John Wiley and Sons Inc. 2022-09-02 /pmc/articles/PMC9437971/ /pubmed/36052959 http://dx.doi.org/10.1002/ctm2.1040 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Mohanta, Sarajo Kumar
Weber, Christian
Yin, Changjun
Habenicht, Andreas J. R.
The dawn has come for new therapeutics to treat atherosclerosis: Targeting neuroimmune cardiovascular interfaces in artery brain circuits
title The dawn has come for new therapeutics to treat atherosclerosis: Targeting neuroimmune cardiovascular interfaces in artery brain circuits
title_full The dawn has come for new therapeutics to treat atherosclerosis: Targeting neuroimmune cardiovascular interfaces in artery brain circuits
title_fullStr The dawn has come for new therapeutics to treat atherosclerosis: Targeting neuroimmune cardiovascular interfaces in artery brain circuits
title_full_unstemmed The dawn has come for new therapeutics to treat atherosclerosis: Targeting neuroimmune cardiovascular interfaces in artery brain circuits
title_short The dawn has come for new therapeutics to treat atherosclerosis: Targeting neuroimmune cardiovascular interfaces in artery brain circuits
title_sort dawn has come for new therapeutics to treat atherosclerosis: targeting neuroimmune cardiovascular interfaces in artery brain circuits
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437971/
https://www.ncbi.nlm.nih.gov/pubmed/36052959
http://dx.doi.org/10.1002/ctm2.1040
work_keys_str_mv AT mohantasarajokumar thedawnhascomefornewtherapeuticstotreatatherosclerosistargetingneuroimmunecardiovascularinterfacesinarterybraincircuits
AT weberchristian thedawnhascomefornewtherapeuticstotreatatherosclerosistargetingneuroimmunecardiovascularinterfacesinarterybraincircuits
AT yinchangjun thedawnhascomefornewtherapeuticstotreatatherosclerosistargetingneuroimmunecardiovascularinterfacesinarterybraincircuits
AT habenichtandreasjr thedawnhascomefornewtherapeuticstotreatatherosclerosistargetingneuroimmunecardiovascularinterfacesinarterybraincircuits
AT mohantasarajokumar dawnhascomefornewtherapeuticstotreatatherosclerosistargetingneuroimmunecardiovascularinterfacesinarterybraincircuits
AT weberchristian dawnhascomefornewtherapeuticstotreatatherosclerosistargetingneuroimmunecardiovascularinterfacesinarterybraincircuits
AT yinchangjun dawnhascomefornewtherapeuticstotreatatherosclerosistargetingneuroimmunecardiovascularinterfacesinarterybraincircuits
AT habenichtandreasjr dawnhascomefornewtherapeuticstotreatatherosclerosistargetingneuroimmunecardiovascularinterfacesinarterybraincircuits